<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9796574</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36588894</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9796574</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fneur.2022.923942</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Summary of key studies within the last 10 years on neuroimaging biomarkers of cognitive recovery after ischemic stroke.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1</label><caption><p>Summary of key studies within the last 10 years on neuroimaging biomarkers of cognitive recovery after ischemic stroke.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Study population, <italic>N</italic>, type of stroke, age</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Duration of study</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Type of imaging and imaging outcomes examined</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Cognitive measures</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Findings</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="6" rowspan="1"><bold>fMRI</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vicentini et al. (<xref rid="B40" ref-type="bibr">40</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">First subacute IS patients with no previous known neurologic disorder. Time 1 (<italic>n</italic> = 37, mean age = 62.92 ± 9.49 years, stroke onset = 24.32 ± 7.44 days, NIHSS: 2.66 ± 3.45). Time 2 after 6 months (<italic>n</italic> = 20, stroke onset: 182.05 ± 8.17 days). Cognitively healthy controls (<italic>n</italic> = 20)</td><td valign="top" align="left" rowspan="1" colspan="1">6 months: 2-time points.<break/> fMRI and cognitive assessments were done at time 1 (subacute phase, within the first month) and 2 (chronic phase, after 6 months).</td><td valign="top" align="left" rowspan="1" colspan="1">rsFC<break/> Three networks were examined: DMN, SN, and CEN network.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA</td><td valign="top" align="left" rowspan="1" colspan="1">At time 1<break/> Patients had weaker interhemispheric connectivity in the DMN than controls (<italic>p</italic> = 0.028, FDR-corrected).<break/> Better cognitive performance was associated with a stronger interhemispheric (<italic>r</italic> = 0.409, FDR <italic>p</italic> = 0.058) and ipsilesional DMN connectivity (<italic>r</italic> = 449, FDR <italic>p</italic> = 0.068) and weaker contralesional SN connectivity (<italic>r</italic> = −0.426, FDR <italic>p</italic> = 0.049)<break/> At time 2<break/> No change in functional connectivity in patients compared to time 1.<break/> Better cognitive recovery at time 2 was associated with stronger DMN connectivity (<italic>r</italic> = 0.511, FDR <italic>p</italic> = 0.090) and weaker SN interhemispheric subacute connectivity (<italic>r</italic> = −0.638, FDR <italic>p</italic> = 0.076)</td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1"><bold>MRI: T1-weighted MRI, T2-weighted MRI, FLAIR</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fruhwirth et al. (<xref rid="B41" ref-type="bibr">41</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Recent small subcortical infarct (RSSI) patients (≤ 25 mm), no preexisting cognitive impairment (<italic>N</italic> = 82, mean age = 61 ± 10 years, 23% female)</td><td valign="top" align="left" rowspan="1" colspan="1">15 months:<break/> Baseline cognitive assessment at time 1 (mean 6 days post-stroke) and time 2 (15 months).<break/> MRI at Time 1.</td><td valign="top" align="left" rowspan="1" colspan="1">WMH lesion volume.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA, Symbol Digital Modalities Test, Comprehensive Trail Making Test</td><td valign="top" align="left" rowspan="1" colspan="1">All patients improved on MoCA, SDMT (processing speed) after 15 months, regardless of WMH severity (<italic>p</italic> = 0.011 for MoCA, <italic>p</italic> = 0.010 for SDMT (processing speed); after age adjustment, no difference between WMH severity and MoCA (<italic>p</italic> = 0.109) or SDMT (processing speed) (<italic>p</italic> = 0.414).<break/> No differences between CTMT-2 (attention) scores and WMH.</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CTMT-5 (set-shifting): no improvement for patients with mild (<italic>p</italic> = 0.086) or moderate-severe WMH (<italic>p</italic> = 0.801) at 15 months, compared to improvement in patients without WMH (<italic>p</italic> = 0.001). Same results even when corrected for age.<break/> WMH volume at baseline was only significant factor that predicted attention at 15 month follow up (<italic>p</italic> = 0.002) beyond demographics.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Scharf et al. (<xref rid="B42" ref-type="bibr">42</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute first-ever ischemic thalamic stroke, &gt;18 yo<break/> Exclusion: previous psychiatric/neuro disorders (<italic>N</italic> = 37 case, 37 controls)</td><td valign="top" align="left" rowspan="1" colspan="1">2 years:<break/> Neuropsychological assessment at time 1 (1 month), time 2 (6 month), time 3 (12 month) and time 4 (24 month)<break/> MRI at time 1, time 2, and time 4.</td><td valign="top" align="left" rowspan="1" colspan="1">MRI—T1, T2, FLAIR, DWI</td><td valign="top" align="left" rowspan="1" colspan="1">Digit span, rivermead behavioral memory test, Regensburg semantic and phonemic word fluency, TMA A/B, Stroop</td><td valign="top" align="left" rowspan="1" colspan="1">Paramedian thalamic stroke patients demonstrated moderate language and executive deficits, with the best recovery of the three thalamic stroke topographies.<break/> Anterior thalamic stroke patients demonstrated the most severe deficits in verbal memory, language, and executive functions, which poorly recovered during follow-up.<break/> Inferolateral stroke patients also suffered from verbal memory, language, and executive deficits; the verbal memory and executive deficits recovered during follow-up, while the language deficits persisted.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B38" ref-type="bibr">38</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (<italic>n</italic> = 199, mean age = 65 ± 13, NIHSS median = 3 (4)</td><td valign="top" align="left" rowspan="1" colspan="1">1 year: cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year).<break/> MRI was done at time 1 only (baseline between 24 and 72 h).</td><td valign="top" align="left" rowspan="1" colspan="1">WMH, deep and lobar microbleeds, enlarged perivascular spaces in basal ganglia and centrum semiovale, previous small deep infarcts, and cSS.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> ZCT processing speed and attention<break/> IST of verbal fluency for executive function.</td><td valign="top" align="left" rowspan="1" colspan="1">- Cognitive performance improved more significantly in the first 3 months. - Severe WMH was identified in 34% of the patients, and cSS in 3.5%.<break/> Patients with severe WMH and focal cSS had overall worse cognitive performances.</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">- Patient with severe WMH had less improvement over time in IST of verbal fluency (β = −0.16, <italic>p</italic> = 0.02) and the number of errors to ZCT (β = 0.19, <italic>p</italic> = 0.02). Those with focal cSS had less improvement over time for ZCT completion time (β = 0.14, <italic>p</italic> = 0.01) and number of errors (β = 0.17, <italic>p</italic> = 0.008).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B39" ref-type="bibr">39</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (<italic>n</italic> = 199, mean age = 67 ± 14, NIHSS ≥1)</td><td valign="top" align="left" rowspan="1" colspan="1">One year: 3-time points cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year).<break/> MRI was done at time 1 only (baseline between 24 and 72 h)</td><td valign="top" align="left" rowspan="1" colspan="1">CMI.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> The Zazzo's cancellation task (ZCT) for processing speed and attention<break/> Issac set a test for verbal fluency (IST)</td><td valign="top" align="left" rowspan="1" colspan="1">The number of CMI was associated with increased time at the ZCT over 1 year regardless of the other MRI markers, stroke severity, and demographic factors (B = 3.84, <italic>P</italic> = 0.01).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B43" ref-type="bibr">43</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute supratentorial ischemic stroke without prestroke disability related to neurological disorder, mRS &gt; 1 at baseline (<italic>N</italic> = 248, mean age 65 ± SD 14 years old, 66% men)</td><td valign="top" align="left" rowspan="1" colspan="1">12 months:<break/> Baseline MRI<break/> Cognitive assessment at time 1 (within 24–72 h), time 2 (after 3 months), and time 3 (after 12 months)</td><td valign="top" align="left" rowspan="1" colspan="1">WMH + stroke volume, gray matter (GM), white matter, and CSF volume.</td><td valign="top" align="left" rowspan="1" colspan="1">Cognitive assessment: MoCA, Isaacs Set Test (IST), Zazzo's cancellation test<break/> Cognitive improvement, stability, or decline calculated using all 3 time points</td><td valign="top" align="left" rowspan="1" colspan="1">- Radiographic model only: total GM volume was the only variable predictive of changes in all cognitive scores over the year of follow-up (<italic>P</italic> &lt; 0.001 for MoCA, <italic>P</italic> = 0.03 for IST, <italic>P</italic> = 0.002 for time to perform Zazzo's cancellation task and <italic>P</italic> &lt; 0.001 for the number of errors)<break/> - In clinical/radiographic model: total GM volume independently associated with cognition [MoCA (<italic>P</italic> = 0.04) and Zazzo's cancellation task (<italic>P</italic> = 0.04)] - GM volume of left fronto-temporo-insular regions, right temporo-insular cortex, and basal ganglia was significantly associated with cognitive improvement.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sung et al. (<xref rid="B44" ref-type="bibr">44</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">First ever ischemic stroke without specific etiologies predisposing to recurrence, cognitive impairment at baseline, neurodegenerative disease (<italic>n</italic> = 112, median age 64.5 (IQR 57.0–73.5) years, NIHSS at baseline 3.77 (IQR: 1.75–5).</td><td valign="top" align="left" rowspan="1" colspan="1">1 year:<break/> MRI and cognitive assessment at time 1 (within 7 days), cognitive assessment again at time 2 (3 months) and time 3 (1 year)</td><td valign="top" align="left" rowspan="1" colspan="1">Stroke location, SVD burden and hippocampal atrophy (HA)<break/> Modified cerebral small vessel disease (mCSVD) score calculated using lacunar infarction, microbleeds, moderate to severe perivascular space at the ganglionic level or a deep white matter Fazekas score ≥ 2.<break/> Medial temporal atrophy score used to determine hippocampal atrophy.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> Weschler Adult Intelligence Scale III, Wechsler Memory Scale III the Semantic Association of Verbal Fluency Test for semantic verbal fluency, Wisconsin Card Sorting Test</td><td valign="top" align="left" rowspan="1" colspan="1">No significant difference in change in MOCA scores between higher CSVD burden or abnormal HA.<break/> In the multivariate model, higher mCSVD score (adjusted odds ratio (aOR) 2.74, 95%CI 1.09–6.86, <italic>p</italic> = 0.032) independently predicted low cognitive performance at 1 year [but not an abnormal MTA score (aOR 1.53, 95%CI 0.56–4.21, <italic>p</italic> = 0.405)]. A combination of a higher mCSVD score and an abnormal MTA score resulted in the highest probability of classification in the LP group (aOR 4.18, 95%CI 1.05–16.66, <italic>p</italic> = 0.043).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Turunen et al. (<xref rid="B45" ref-type="bibr">45</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">First ever supratentorial ischemic stroke, no baseline neurological or psychiatric disorder (<italic>n</italic> = 132, mean age 54 years, 68.2% male)</td><td valign="top" align="left" rowspan="1" colspan="1">6 months:<break/> Baseline imaging<break/> Cognitive assessment at time 1 (~8 days post-stroke) and time 2 (6 month follow up)</td><td valign="top" align="left" rowspan="1" colspan="1">Stroke location, categorized into two groups: infarction in cortical gray matter (including additional white matter) or infarction in subcortical gray and/or white matter.</td><td valign="top" align="left" rowspan="1" colspan="1">Weschler memory scale, phonemic fluency task, TMA A/B, WMS-R, searching task<break/> On 6-month repeat, general intellect added</td><td valign="top" align="left" rowspan="1" colspan="1">No differences in the recovery of cognitive profile amongst lesion location groups were found; after adjusting for baseline scores, the lesion location groups did not differ at follow-up.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang et al. (<xref rid="B46" ref-type="bibr">46</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Imaging confirmed first time acute ischemic stroke, no history of cognitive or psychiatric disorder (<italic>n</italic> = 865, mean age 59.67 ± 10.92 years and 74.22% male)</td><td valign="top" align="left" rowspan="1" colspan="1">12 months:<break/> Baseline imaging<break/> Baseline MOCA at time 1 (2 weeks/discharge) and time 2 (12 month follow-up)</td><td valign="top" align="left" rowspan="1" colspan="1">Infarct location, small vessel disease features, WMHs, lacunes, microbleeds, enlarged perivascular spaces, cortical atrophy</td><td valign="top" align="left" rowspan="1" colspan="1">MOCA<break/> Cognitive decline defined as reduction of 2+ points between time 1 and time 2, improvement defined as increase of 2+ between time points, cognitive stability defined as change of &lt; 2 points.</td><td valign="top" align="left" rowspan="1" colspan="1">In cognitive decline group, statistically significantly higher incidence of thalamic (11.43 vs. 5.66%, <italic>p</italic> = 0.023) and right sided lesions (6.67 vs. 1.97%, <italic>p</italic> = 0.004).<break/> Thalamic infarction increased risk of cognitive decline (OR 2.152, 95% CI 1.095–4.227).<break/> Thalamic infarction quadrupled the risk of cognitive decline (OR 4.873, 95% CI 1.634–14.534) in fully adjusted model.</td></tr><tr><td valign="top" align="left" colspan="6" rowspan="1"><bold>MRI: DTI, DWI</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aben et al. (<xref rid="B47" ref-type="bibr">47</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemic stroke patients with no prior cognitive disorder [<italic>n</italic> = 75, mean age = 70 ±8.5, NIHSS =2 (2–4)]</td><td valign="top" align="left" rowspan="1" colspan="1">1 year: 2- time points<break/> Cognitive assessments were done at time 1 (baseline 5 weeks ±1 week) and time 2 (after 1 year). MRI was done at time 1 only.</td><td valign="top" align="left" rowspan="1" colspan="1">Lesion impact score, calculated by multiplying the percentage of node volume affected by the infarct with the node's corresponding hub-score.</td><td valign="top" align="left" rowspan="1" colspan="1">4 cognitive domains: attention and processing speed, working memory and learning, and frontal executive function</td><td valign="top" align="left" rowspan="1" colspan="1">- A higher lesion impact score, indicating an increasing infarct size in nodes with a higher hub-score, was related to lower global brain network efficiency [β = −0.528 (−0.776 to −0.277); <italic>P</italic> &lt; 0.001].<break/> - A lower lesion impact score was an independent predictor of cognitive recovery 1 year after stroke [OR = 0.434 (0.193–0.978); <italic>P</italic> = 0.044].</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aben et al. (<xref rid="B48" ref-type="bibr">48</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemic stroke patients (<italic>n</italic> = 217, aged ≥50 years, and MoCA &lt; 26 during hospitalization)</td><td valign="top" align="left" rowspan="1" colspan="1">1 year: 2- time points<break/> Cognitive assessments were done at time 1 (baseline 5 weeks) and time 2 (after 1 year). MRI was done at time 1 only.</td><td valign="top" align="left" rowspan="1" colspan="1">4 DWI-based measures of brain connectivity: global network efficiency and mean connectivity strength, both weighted for MD and FA.</td><td valign="top" align="left" rowspan="1" colspan="1">MoCA</td><td valign="top" align="left" rowspan="1" colspan="1">- Of 135 patients with PSCI at time 1, 41 (30%) showed cognitive recovery.<break/> three out of four DTI measures of brain connectivity: global efficiency FA weighted, mean connectivity strength FA weighted, and mean connectivity strength MD weighted predict cognitive recovery 1 year after IS. These measures, however, did not add a better predictive value over the multivariable model.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kuceyeski et al. (<xref rid="B49" ref-type="bibr">49</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">IS patients (<italic>n</italic> = 40, mean age = 68.1 ± 13.2 years, NIHSS: 6.8 ± 5.6)</td><td valign="top" align="left" rowspan="1" colspan="1">6 months<break/> Cognitive assessment after discharge and at 6 months.<break/> Imaging was done at baseline (within 14 days)</td><td valign="top" align="left" rowspan="1" colspan="1">Connectome disruption at three levels: whole brain, individual gray matter regions and between pairs of gray matter regions.<break/> Lesion volume model for comparison.</td><td valign="top" align="left" rowspan="1" colspan="1">Computer adaptive version of the Activity Measure for Post-Acute Care.</td><td valign="top" align="left" rowspan="1" colspan="1">- The regional disconnection model best predicted applied cognitive functioning (<italic>R</italic><sup>2</sup> = 0.56)<break/> - The pairwise disconnection model best predicted the daily activity measure (<italic>R</italic><sup>2</sup> = 0.72)</td></tr></tbody></table><table-wrap-foot><p>fMRI, Functional Magnetic Resonance Imaging; FLAIR, Fluid-Attenuated Inversion Recovery; DTI, Diffusion Tensor Imaging; DWI, Diffusion-Weighted Imaging; IS, Ischemic Stroke; rsFC, resting-state functional connectivity; DMN, Default Mode Network; SN, Salience Network; CEN, Central Executive network; MoCA, Montreal Cognitive Assessment; MMSE, Mini-Mental State Examination; PSCI, Post-Stroke Cognitive Impairment; PCC, Posterior Cingulate Cortex; PCu, Precuneus; MPFC, Medial Prefrontal Cortex; FIM, Functional-Independence Measures; WMH, White Matter Hyperintensities; NFL, Neurofilament Lights; ZCT, Zazzo's Cancellation Task; IST, Issac Set a Test; cSS, Cortical Superficial Siderosis; CMI, Cortical Cerebral Microinfarct; MD, Mean Diffusivity; FA, Fractional Anisotropy; GPT, Grooved Pegboard Test.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of key studies within the last 10 years on neuroimaging biomarkers of cognitive recovery after ischemic stroke.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">References</th><th valign="top" align="left">Study population, N, type of stroke, age</th><th valign="top" align="left">Duration of study</th><th valign="top" align="left">Type of imaging and imaging outcomes examined</th><th valign="top" align="left">Cognitive measures</th><th valign="top" align="left">Findings</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="6">fMRI</td></tr><tr><td valign="top" align="left">Vicentini et al. (???)</td><td valign="top" align="left">First subacute IS patients with no previous known neurologic disorder. Time 1 (n = 37, mean age = 62.92 ± 9.49 years, stroke onset = 24.32 ± 7.44 days, NIHSS: 2.66 ± 3.45). Time 2 after 6 months (n = 20, stroke onset: 182.05 ± 8.17 days). Cognitively healthy controls (n = 20)</td><td valign="top" align="left">6 months: 2-time points. fMRI and cognitive assessments were done at time 1 (subacute phase, within the first month) and 2 (chronic phase, after 6 months).</td><td valign="top" align="left">rsFC Three networks were examined: DMN, SN, and CEN network.</td><td valign="top" align="left">MoCA</td><td valign="top" align="left">At time 1 Patients had weaker interhemispheric connectivity in the DMN than controls (p = 0.028, FDR-corrected). Better cognitive performance was associated with a stronger interhemispheric (r = 0.409, FDR p = 0.058) and ipsilesional DMN connectivity (r = 449, FDR p = 0.068) and weaker contralesional SN connectivity (r = −0.426, FDR p = 0.049) At time 2 No change in functional connectivity in patients compared to time 1. Better cognitive recovery at time 2 was associated with stronger DMN connectivity (r = 0.511, FDR p = 0.090) and weaker SN interhemispheric subacute connectivity (r = −0.638, FDR p = 0.076)</td></tr><tr><td valign="top" align="left" colspan="6">MRI: T1-weighted MRI, T2-weighted MRI, FLAIR</td></tr><tr><td valign="top" align="left">Fruhwirth et al. (???)</td><td valign="top" align="left">Recent small subcortical infarct (RSSI) patients (≤ 25 mm), no preexisting cognitive impairment (N = 82, mean age = 61 ± 10 years, 23% female)</td><td valign="top" align="left">15 months: Baseline cognitive assessment at time 1 (mean 6 days post-stroke) and time 2 (15 months). MRI at Time 1.</td><td valign="top" align="left">WMH lesion volume.</td><td valign="top" align="left">MoCA, Symbol Digital Modalities Test, Comprehensive Trail Making Test</td><td valign="top" align="left">All patients improved on MoCA, SDMT (processing speed) after 15 months, regardless of WMH severity (p = 0.011 for MoCA, p = 0.010 for SDMT (processing speed); after age adjustment, no difference between WMH severity and MoCA (p = 0.109) or SDMT (processing speed) (p = 0.414). No differences between CTMT-2 (attention) scores and WMH.</td></tr><tr><td valign="top" align="left" colspan="5"/><td valign="top" align="left">CTMT-5 (set-shifting): no improvement for patients with mild (p = 0.086) or moderate-severe WMH (p = 0.801) at 15 months, compared to improvement in patients without WMH (p = 0.001). Same results even when corrected for age. WMH volume at baseline was only significant factor that predicted attention at 15 month follow up (p = 0.002) beyond demographics.</td></tr><tr><td valign="top" align="left">Scharf et al. (???)</td><td valign="top" align="left">Acute first-ever ischemic thalamic stroke, &gt;18 yo Exclusion: previous psychiatric/neuro disorders (N = 37 case, 37 controls)</td><td valign="top" align="left">2 years: Neuropsychological assessment at time 1 (1 month), time 2 (6 month), time 3 (12 month) and time 4 (24 month) MRI at time 1, time 2, and time 4.</td><td valign="top" align="left">MRI—T1, T2, FLAIR, DWI</td><td valign="top" align="left">Digit span, rivermead behavioral memory test, Regensburg semantic and phonemic word fluency, TMA A/B, Stroop</td><td valign="top" align="left">Paramedian thalamic stroke patients demonstrated moderate language and executive deficits, with the best recovery of the three thalamic stroke topographies. Anterior thalamic stroke patients demonstrated the most severe deficits in verbal memory, language, and executive functions, which poorly recovered during follow-up. Inferolateral stroke patients also suffered from verbal memory, language, and executive deficits; the verbal memory and executive deficits recovered during follow-up, while the language deficits persisted.</td></tr><tr><td valign="top" align="left">Sagnier et al. (???)</td><td valign="top" align="left">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (n = 199, mean age = 65 ± 13, NIHSS median = 3 (4)</td><td valign="top" align="left">1 year: cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year). MRI was done at time 1 only (baseline between 24 and 72 h).</td><td valign="top" align="left">WMH, deep and lobar microbleeds, enlarged perivascular spaces in basal ganglia and centrum semiovale, previous small deep infarcts, and cSS.</td><td valign="top" align="left">MoCA ZCT processing speed and attention IST of verbal fluency for executive function.</td><td valign="top" align="left">- Cognitive performance improved more significantly in the first 3 months. - Severe WMH was identified in 34% of the patients, and cSS in 3.5%. Patients with severe WMH and focal cSS had overall worse cognitive performances.</td></tr><tr><td valign="top" align="left" colspan="5"/><td valign="top" align="left">- Patient with severe WMH had less improvement over time in IST of verbal fluency (β = −0.16, p = 0.02) and the number of errors to ZCT (β = 0.19, p = 0.02). Those with focal cSS had less improvement over time for ZCT completion time (β = 0.14, p = 0.01) and number of errors (β = 0.17, p = 0.008).</td></tr><tr><td valign="top" align="left">Sagnier et al. (???)</td><td valign="top" align="left">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (n = 199, mean age = 67 ± 14, NIHSS ≥1)</td><td valign="top" align="left">One year: 3-time points cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year). MRI was done at time 1 only (baseline between 24 and 72 h)</td><td valign="top" align="left">CMI.</td><td valign="top" align="left">MoCA The Zazzo's cancellation task (ZCT) for processing speed and attention Issac set a test for verbal fluency (IST)</td><td valign="top" align="left">The number of CMI was associated with increased time at the ZCT over 1 year regardless of the other MRI markers, stroke severity, and demographic factors (B = 3.84, P = 0.01).</td></tr><tr><td valign="top" align="left">Sagnier et al. (???)</td><td valign="top" align="left">Acute supratentorial ischemic stroke without prestroke disability related to neurological disorder, mRS &gt; 1 at baseline (N = 248, mean age 65 ± SD 14 years old, 66% men)</td><td valign="top" align="left">12 months: Baseline MRI Cognitive assessment at time 1 (within 24–72 h), time 2 (after 3 months), and time 3 (after 12 months)</td><td valign="top" align="left">WMH + stroke volume, gray matter (GM), white matter, and CSF volume.</td><td valign="top" align="left">Cognitive assessment: MoCA, Isaacs Set Test (IST), Zazzo's cancellation test Cognitive improvement, stability, or decline calculated using all 3 time points</td><td valign="top" align="left">- Radiographic model only: total GM volume was the only variable predictive of changes in all cognitive scores over the year of follow-up (P &lt; 0.001 for MoCA, P = 0.03 for IST, P = 0.002 for time to perform Zazzo's cancellation task and P &lt; 0.001 for the number of errors) - In clinical/radiographic model: total GM volume independently associated with cognition [MoCA (P = 0.04) and Zazzo's cancellation task (P = 0.04)] - GM volume of left fronto-temporo-insular regions, right temporo-insular cortex, and basal ganglia was significantly associated with cognitive improvement.</td></tr><tr><td valign="top" align="left">Sung et al. (???)</td><td valign="top" align="left">First ever ischemic stroke without specific etiologies predisposing to recurrence, cognitive impairment at baseline, neurodegenerative disease (n = 112, median age 64.5 (IQR 57.0–73.5) years, NIHSS at baseline 3.77 (IQR: 1.75–5).</td><td valign="top" align="left">1 year: MRI and cognitive assessment at time 1 (within 7 days), cognitive assessment again at time 2 (3 months) and time 3 (1 year)</td><td valign="top" align="left">Stroke location, SVD burden and hippocampal atrophy (HA) Modified cerebral small vessel disease (mCSVD) score calculated using lacunar infarction, microbleeds, moderate to severe perivascular space at the ganglionic level or a deep white matter Fazekas score ≥ 2. Medial temporal atrophy score used to determine hippocampal atrophy.</td><td valign="top" align="left">MoCA Weschler Adult Intelligence Scale III, Wechsler Memory Scale III the Semantic Association of Verbal Fluency Test for semantic verbal fluency, Wisconsin Card Sorting Test</td><td valign="top" align="left">No significant difference in change in MOCA scores between higher CSVD burden or abnormal HA. In the multivariate model, higher mCSVD score (adjusted odds ratio (aOR) 2.74, 95%CI 1.09–6.86, p = 0.032) independently predicted low cognitive performance at 1 year [but not an abnormal MTA score (aOR 1.53, 95%CI 0.56–4.21, p = 0.405)]. A combination of a higher mCSVD score and an abnormal MTA score resulted in the highest probability of classification in the LP group (aOR 4.18, 95%CI 1.05–16.66, p = 0.043).</td></tr><tr><td valign="top" align="left">Turunen et al. (???)</td><td valign="top" align="left">First ever supratentorial ischemic stroke, no baseline neurological or psychiatric disorder (n = 132, mean age 54 years, 68.2% male)</td><td valign="top" align="left">6 months: Baseline imaging Cognitive assessment at time 1 (~8 days post-stroke) and time 2 (6 month follow up)</td><td valign="top" align="left">Stroke location, categorized into two groups: infarction in cortical gray matter (including additional white matter) or infarction in subcortical gray and/or white matter.</td><td valign="top" align="left">Weschler memory scale, phonemic fluency task, TMA A/B, WMS-R, searching task On 6-month repeat, general intellect added</td><td valign="top" align="left">No differences in the recovery of cognitive profile amongst lesion location groups were found; after adjusting for baseline scores, the lesion location groups did not differ at follow-up.</td></tr><tr><td valign="top" align="left">Zhang et al. (???)</td><td valign="top" align="left">Imaging confirmed first time acute ischemic stroke, no history of cognitive or psychiatric disorder (n = 865, mean age 59.67 ± 10.92 years and 74.22% male)</td><td valign="top" align="left">12 months: Baseline imaging Baseline MOCA at time 1 (2 weeks/discharge) and time 2 (12 month follow-up)</td><td valign="top" align="left">Infarct location, small vessel disease features, WMHs, lacunes, microbleeds, enlarged perivascular spaces, cortical atrophy</td><td valign="top" align="left">MOCA Cognitive decline defined as reduction of 2+ points between time 1 and time 2, improvement defined as increase of 2+ between time points, cognitive stability defined as change of &lt; 2 points.</td><td valign="top" align="left">In cognitive decline group, statistically significantly higher incidence of thalamic (11.43 vs. 5.66%, p = 0.023) and right sided lesions (6.67 vs. 1.97%, p = 0.004). Thalamic infarction increased risk of cognitive decline (OR 2.152, 95% CI 1.095–4.227). Thalamic infarction quadrupled the risk of cognitive decline (OR 4.873, 95% CI 1.634–14.534) in fully adjusted model.</td></tr><tr><td valign="top" align="left" colspan="6">MRI: DTI, DWI</td></tr><tr><td valign="top" align="left">Aben et al. (???)</td><td valign="top" align="left">Ischemic stroke patients with no prior cognitive disorder [n = 75, mean age = 70 ±8.5, NIHSS =2 (2–4)]</td><td valign="top" align="left">1 year: 2- time points Cognitive assessments were done at time 1 (baseline 5 weeks ±1 week) and time 2 (after 1 year). MRI was done at time 1 only.</td><td valign="top" align="left">Lesion impact score, calculated by multiplying the percentage of node volume affected by the infarct with the node's corresponding hub-score.</td><td valign="top" align="left">4 cognitive domains: attention and processing speed, working memory and learning, and frontal executive function</td><td valign="top" align="left">- A higher lesion impact score, indicating an increasing infarct size in nodes with a higher hub-score, was related to lower global brain network efficiency [β = −0.528 (−0.776 to −0.277); P &lt; 0.001]. - A lower lesion impact score was an independent predictor of cognitive recovery 1 year after stroke [OR = 0.434 (0.193–0.978); P = 0.044].</td></tr><tr><td valign="top" align="left">Aben et al. (???)</td><td valign="top" align="left">Ischemic stroke patients (n = 217, aged ≥50 years, and MoCA &lt; 26 during hospitalization)</td><td valign="top" align="left">1 year: 2- time points Cognitive assessments were done at time 1 (baseline 5 weeks) and time 2 (after 1 year). MRI was done at time 1 only.</td><td valign="top" align="left">4 DWI-based measures of brain connectivity: global network efficiency and mean connectivity strength, both weighted for MD and FA.</td><td valign="top" align="left">MoCA</td><td valign="top" align="left">- Of 135 patients with PSCI at time 1, 41 (30%) showed cognitive recovery. three out of four DTI measures of brain connectivity: global efficiency FA weighted, mean connectivity strength FA weighted, and mean connectivity strength MD weighted predict cognitive recovery 1 year after IS. These measures, however, did not add a better predictive value over the multivariable model.</td></tr><tr><td valign="top" align="left">Kuceyeski et al. (???)</td><td valign="top" align="left">IS patients (n = 40, mean age = 68.1 ± 13.2 years, NIHSS: 6.8 ± 5.6)</td><td valign="top" align="left">6 months Cognitive assessment after discharge and at 6 months. Imaging was done at baseline (within 14 days)</td><td valign="top" align="left">Connectome disruption at three levels: whole brain, individual gray matter regions and between pairs of gray matter regions. Lesion volume model for comparison.</td><td valign="top" align="left">Computer adaptive version of the Activity Measure for Post-Acute Care.</td><td valign="top" align="left">- The regional disconnection model best predicted applied cognitive functioning (R2 = 0.56) - The pairwise disconnection model best predicted the daily activity measure (R2 = 0.72)</td></tr></tbody></table></div>fMRI, Functional Magnetic Resonance Imaging; FLAIR, Fluid-Attenuated Inversion Recovery; DTI, Diffusion Tensor Imaging; DWI, Diffusion-Weighted Imaging; IS, Ischemic Stroke; rsFC, resting-state functional connectivity; DMN, Default Mode Network; SN, Salience Network; CEN, Central Executive network; MoCA, Montreal Cognitive Assessment; MMSE, Mini-Mental State Examination; PSCI, Post-Stroke Cognitive Impairment; PCC, Posterior Cingulate Cortex; PCu, Precuneus; MPFC, Medial Prefrontal Cortex; FIM, Functional-Independence Measures; WMH, White Matter Hyperintensities; NFL, Neurofilament Lights; ZCT, Zazzo's Cancellation Task; IST, Issac Set a Test; cSS, Cortical Superficial Siderosis; CMI, Cortical Cerebral Microinfarct; MD, Mean Diffusivity; FA, Fractional Anisotropy; GPT, Grooved Pegboard Test.</transformed-table></extracted-table></extracted-tables-set>